Annovis Bio is down -12.0%, or -$1.19 to $8.75.
Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on ANVS:
- Largest borrow rate increases among liquid names
- Annovis Bio Announces Last Patient Last Visit in the Phase II/III Study of Buntanetap in Alzheimer’s Disease
- Annovis announces last patient last visit in Phase II/III study of buntanetap
- Annovis Bio falls -9.6%
- Annovis Bio files $250M mixed securities shelf